Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 29.20M | £ 25.00M | £ 324.30M | £ 22.90M | £ 19.30M |
Total Assets | £ 1.96B | £ 1.75B | £ 1.63B | £ 1.33B | £ 611.20M |
Total Debt | £ 520.70M | £ 477.80M | £ 549.50M | £ 287.70M | £ 106.10M |
Net Debt | £ 491.50M | £ 452.80M | £ 225.20M | £ 264.80M | £ 86.80M |
Total Liabilities | £ 897.40M | £ 816.90M | £ 768.80M | £ 507.50M | £ 229.90M |
Stockholders Equity | £ 1.06B | £ 931.20M | £ 862.30M | £ 819.20M | £ 381.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |